Holdings

Vivo Capital, LLC

As of Sep 30, 2026, Vivo Capital, LLC reported 47 positions worth US$829M. Largest: Praxis Precision Medicines, Inc., Trevi Therapeutics, Inc. and Erasca, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Praxis Precision Medicines, Inc.271KUS$79Mno changeSep 30, 2026
Trevi Therapeutics, Inc.4.23MUS$60.6M−865KSep 30, 2026
Erasca, Inc.4.02MUS$58.9M−107KSep 30, 2026
ArriVent BioPharma, Inc.1.79MUS$54.1M+105KSep 30, 2026
Abivax SA415KUS$41.1Mno changeSep 30, 2026
Aclaris Therapeutics, Inc.6.69MUS$35.2Mno changeSep 30, 2026
Alto Neuroscience, Inc.1.36MUS$34.7M+151KSep 30, 2026
Tango Therapeutics, Inc.1.38MUS$34.4Mno changeSep 30, 2026
Corvus Pharmaceuticals, Inc.2.81MUS$32.3Mno changeSep 30, 2026
LB Pharmaceuticals Inc800KUS$30.7Mno changeSep 30, 2026